Swiss Institute for Medical Cannabis Research
Advancing Patient-Centered Cannabinoid Therapies Through Clinical Research and Physician Education
The Swiss Institute for Medical Cannabis Research (SIMCR) is a nonprofit scientific institute based in Lausanne, Switzerland, dedicated to advancing the scientific understanding of the endocannabinoid system and the responsible clinical integration of cannabinoid therapeutics through education and patient-centered research.
With a particular focus on the endocannabinoid system as a foundational regulatory system in human physiology, SIMCR works to equip physicians, researchers, and healthcare professionals with the knowledge, frameworks, and clinical evidence required to integrate cannabinoid science into real-world medical practice.
Why This Matters
Bridging Science and Clinical Practice
Over the past decades, scientific understanding of the endocannabinoid system (ECS) has expanded significantly. This biological system plays a central role in regulating key physiological processes, including pain modulation, immune response, mood regulation, and overall homeostasis.
Despite this progress, a critical gap persists between scientific knowledge and clinical application.
Key challenges include:
- Limited physician education on the endocannabinoid system
- Insufficient clinical research on full-spectrum cannabinoid therapeutics
- Lack of standardized, patient-centered treatment frameworks
- Barriers to safe and supervised patient access
- Fragmentation between research, clinical practice, and patient experience
SIMCR was established to address this gap by building structured, evidence-based pathways that connect scientific knowledge to clinical implementation.
Two Pillars
Our Two Core Pillars
SIMCR operates at the intersection of research, education, and patient-centered care through two core pillars.
The institute also functions within a broader ecosystem of scientific, educational, and collaborative initiatives that support its long-term research, clinical, and institutional objectives.
Education
SIMCR Academy
Providing structured, CME-certified and physician-reviewed scientific education for physicians and healthcare professionals.
The SIMCR Academy is designed to:
- Deliver rigorous, evidence-based education on the endocannabinoid system
- Equip physicians and healthcare professionals with clinically relevant knowledge
- Support the integration of cannabinoid medicine into modern healthcare systems
- Establish standardized, high-quality educational frameworks
- Enable international scalability through structured and accredited programs
This pillar ensures that medical professionals are equipped to apply cannabinoid science in a safe, responsible, and clinically meaningful manner.
Clinical Research
Patient-Centered Protocols
Designing and implementing patient-centered clinical research focused on full-spectrum cannabinoid therapeutics.
This includes:
- Development of structured clinical research protocols
- Generation of high-quality clinical evidence through real-world data collection
- Focus on patient-centered outcomes and therapeutic relevance
- Collaboration with physicians, clinics, and research partners
- Collection, management, and analysis of clinically meaningful datasets
- Use of standardized, clinically relevant cannabinoid formulations within research protocols
The research scope includes emerging areas of scientific interest, such as acidic cannabinoids and their potential clinical relevance, evaluated within a rigorous and clinically grounded framework.
The objective is to generate credible, high-quality clinical evidence supporting the responsible clinical integration of cannabinoid therapies into modern medical practice, with patient dignity and medically supervised care as foundational principles of every protocol.
Swiss Institutional Standards
Our Institutional Approach
SIMCR is structured as a Swiss scientific institute, operating under the governance, ethical, and compliance standards that define clinical and research activity in Switzerland. Our institutional framework is built around scientifically rigorous methodology, medically supervised patient care, and transparent oversight.
Operating within the Swiss regulatory environment is central to how SIMCR functions: it shapes the way protocols are designed, how data is handled, and how the institute upholds the credibility required of a serious clinical and scientific organization.
- Scientific rigor applied to every research activity
- Methodological transparency and data integrity
- Patient safety and medically supervised care within all clinical protocols
- Governance and compliance aligned with Swiss regulatory standards
- Ethical oversight and institutional accountability across research and education
Selective Partnerships
Collaborate With Us
SIMCR works with a limited number of scientifically and clinically aligned partners. We engage with physicians, researchers, academic institutions, and medical educators whose methodology, clinical standards, and commitment to patient-centered science are consistent with our own.
In practice, collaboration with SIMCR means co-developing clinical research protocols, contributing to physician training programs within the SIMCR Academy, and participating in structured data and evidence frameworks.
We prioritize partnerships that contribute directly to:
- Co-developing structured clinical research protocols
- Contributing to physician education and CME-certified training
- Generating and sharing high-quality clinical data
- Integrating endocannabinoid science into clinical practice
Supporting the Mission
As a nonprofit scientific institute, SIMCR relies on the support of individuals and organizations committed to advancing responsible, evidence-based cannabinoid medicine.
All contributions directly support the advancement of patient-centered research, physician education, and the integration of endocannabinoid science into modern healthcare systems.
Contact Us to Discuss Supporting the MissionSupport enables:
- Development and execution of clinical research protocols
- Data collection, analysis, and publication
- Patient access to supervised cannabinoid-based treatments within research frameworks
- Provision of standardized cannabinoid formulations used within clinical research
- Expansion of educational programs through the SIMCR Academy
- Development of institutional, operational, and compliance infrastructure